Article
LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
3 Jul 2021
Abstract excerpt
BACKGROUND: Clear cell renal cell carcinoma (ccRCC), derived from renal tubular epithelial cells, is the most common malignant tumor of the kidney. The study of key genes related to the pathogenesis of ccRCC has become important for gene target therapy. METHODS: Bioinformatics analysis of The Cancer Genome Atlas (TCGA), the NCBI Gene Expression Omnibus (GEO) database, USUC Xena database, cBioPortal for Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
